| Sanofi-Aventis (Suisse) SA - Lasix, comprimés |
| 30629 | | 01 | | Lasix | | comprimés | | C03CA01 | | Furosemide | | 14.09.1964 | | |
|
| Composition |
| furosemidum 40 mg, lactosum monohydricum 53 mg, maydis amylum, amylum pregelificatum, talcum, magnesii stearas, silica colloidalis anhydrica, pro compresso. |
| Packungsbestandteile |
| Tablets | | | | | Active Agent | Dose |
|---|
| Furosemide | 40 mg |
| | BAG: Active Agent | Dose |
|---|
| Furosemide | 40 mg |
| | | | Inactive agents | Dose |
|---|
| Amylum Pregelificatum | | | Lactose Monohydrate | 53 mg | | Magnesii Stearas | | | Maydis Amylum | | | Pro Compresso | | | Silica Colloidalis Anhydrica | | | Talcum | |
| |
|
| Teilbarkeit |
| | Ja | | | | Wahrscheinlich suspendierbar | | | | Ja | | | | -- | | | | Vorschlag: Lasix Ampullen können peroral verabreicht werden, die Lösung hat aber einen seifigen Geschmack. | | | | | |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 50 | | | B | | Yes | | 019 | 12 Tablet(s) | | 10.10 | B | SL | No | | 027 | 50 Tablet(s) | 3.34 | 12.85 | B | SL | No |
|
